Model Evaluation Summary
The final machine learning model was evaluated on the test set using standard classification metrics. Here are the key results:

1. Classification Report
For class 0 (No lung cancer):

Precision: 0.83
When the model predicts “no cancer,” it is correct 83% of the time.

Recall: 0.71
It correctly identifies 71% of actual non-cancer cases.

F1-score: 0.77
This combines precision and recall into one score (the harmonic mean).

Support: 7
There were 7 true cases in the test set for this class.

For class 1 (Lung cancer):

Precision: 0.98
When the model predicts “cancer,” it is correct 98% of the time.

Recall: 0.99
It correctly identifies 99% of all lung cancer cases.

F1-score: 0.98
Indicates superb precision and recall balance.

Support: 86
There were 86 true cases in the test set for this class.

Accuracy of the model:
The overall accuracy is 0.97, meaning 97% of the predictions made by the model are correct across the test set.

Macro average:
Precision: 0.91, Recall: 0.85, F1-score: 0.88
Macro average calculates the unweighted mean performance across both classes (treats them equally).

Weighted average:
Precision: 0.97, Recall: 0.97, F1-score: 0.97
Weighted average considers the distribution of each class (so most of your test cases are cancer, hence high scores).

2. Confusion Matrix:
True Negatives (TN): 5 — Correctly predicted no cancer.
False Positives (FP): 2 — Incorrectly predicted cancer when there was none.
False Negatives (FN): 1 — Missed a cancer case (predicted no cancer when there was cancer).
True Positives (TP): 85 — Correctly identified lung cancer cases.

3. Key Interpretations:
Overall accuracy is 0.97 (97%), meaning the model makes correct predictions for 97% of test cases.
Recall for cancer cases (1) is exceptionally high (0.99):
The model successfully identified 99% of cancer cases.
Only 1 actual cancer case was missed.
Precision for cancer cases (0.98):
When the model predicts "cancer," it is correct 98% of the time.
Performance for "no cancer" (class 0) is lower (recall 0.71):
The model is more cautious and sometimes predicts cancer when there isn't any (2 false positives out of 7 real negatives), perhaps due to class imbalance (many more cancer cases than non-cancer cases in data).

4. Practical Meaning
Strengths:
The model is highly effective at detecting lung cancer cases (very low false negative rate).
Rarely will it fail to identify a true cancer patient—a critical property in medical screening.
Caution:
Slightly less accurate at ruling out non-cancer (more false positives), which could lead to unnecessary follow-up for some, but this is generally preferable to missing a real case in medical contexts.
Class imbalance:
There are far more cancer cases than non-cancer in your test set, which affects precision/recall on the less common class (no cancer).

5. Conclusion
The model demonstrates excellent performance on cancer detection, making it well suited for medical risk screening applications where high recall is crucial. The feature importance analysis combined with these metrics provides transparent, actionable, and trustworthy insights for both technical and non-technical audiences.
For even greater rigor, additional analysis (cross-validation, ROC/PR curves, calibration plots) can be included if required for publication or clinical use.
